Thank you for your support and patience as Humble has worked to prepare our Premarket Tobacco Product Application (PMTA) submission. We are pleased to report that on Thursday Sept 3rd 2020, Humble submitted its PMTA to the U.S. Food and Drug Administration.
As a producer of e-liquid products, Humble is required to go through the PMTA process to remain on the market. The goal of our submission is to receive marketing orders from FDA for our suite of e-liquid products, allowing us to continue providing our retailers, distributors and consumers with high-quality, flavor-filled e-juice for the long term.
Our team dedicated significant time and resources into preparing our PMTA submission. We are confident in our submission and look forward to the next step in the PMTA journey: the formal acceptance of our application by FDA.
We are excited to share more information with you as soon as we can and are here if you have questions in the meantime.
We are pleased to announce that we have received our Premarket Tobacco Product Application (PMTA) acceptance letter from the U.S. Food and Drug Administration. We submitted our application to the FDA on Sept. 3rd, and we are seeking the FDA’s authorization for the marketing and sale of our suite of e-liquid products.